Clinical Toxicology · 2008 · 15 citations · 17 references
PharmacyPharmacologyToxicologyNeurotoxicologySubstance Abuse ToxicologySubstance Use DisordersAddictionClinical Manifestations Of IntoxicationDrug DependenceDrugs Of AbuseOpioid PharmacologyOpioid ToxicologyAnalytical Liquid ChromatographyAtypical Syndrome RecognitionBeta2-adrenergic Agonist TherapyHeroin ToxicologyPoisoning Case SeriesSerum Creatine Kinase Assessment
BACKGROUND: Clenbuterol is a potent, long-acting beta-adrenergic agonist that has been reported as an adulterant of heroin. We describe an atypical syndrome in five users of clenbuterol-tainted heroin. METHODS: All cases were referred to a regional Poison Control Center. Urine and blood were analyzed using gas and liquid chromatography as well as mass spectrometry. CASE SERIES: Five heroin users presented with a syndrome characterized by muscular spasm, tremor, hyperreflexia, and elevated serum creatine phosphokinase concentrations. All patients lacked findings of acute clenbuterol toxicity but tested positive for clenbuterol and negative for strychnine and a battery of common potential adulterants. CONCLUSIONS: We report five cases of a novel neuromuscular syndrome in users of clenbuterol-adulterated heroin. It is unclear whether these reactions represent an atypical response to clenbuterol or another unidentified contaminant.
17
Food poisoning by clenbuterol in Portugal
Jorge Barbosa, Clara Cruz, J.M. Martins et al. · Food Additives & Contaminants · 2005 · 157 citations
Pharmacy, Food Science, Toxicology +12
Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain.
L. Salleras, A Domínguez, Enrique Mata et al. · PubMed · 1995 · 102 citations